Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Sell
202
-99
-33% -$11.4K ﹤0.01% 1135
2026
Q1
$36K Hold
301
﹤0.01% 1010
2025
Q4
$41K Buy
301
+1
+0.3% +$144 ﹤0.01% 956
2025
Q3
$45K Buy
300
+200
+200% +$27.7K ﹤0.01% 909
2025
Q2
$13K Hold
100
﹤0.01% 1102
2025
Q1
$12K Hold
100
﹤0.01% 1101
2024
Q4
$12K Hold
100
﹤0.01% 1040
2024
Q3
$14K Hold
100
﹤0.01% 971
2024
Q2
$14K Hold
100
﹤0.01% 917
2024
Q1
$13K Hold
100
﹤0.01% 897
2023
Q4
$11K Hold
100
﹤0.01% 895
2023
Q3
$9K Hold
100
﹤0.01% 905
2023
Q2
$11K Sell
100
-105
-51% -$11.1K ﹤0.01% 812
2023
Q1
$21K Hold
205
﹤0.01% 729
2022
Q4
$23K Hold
205
﹤0.01% 740
2022
Q3
$18K Hold
205
﹤0.01% 734
2022
Q2
$16K Hold
205
﹤0.01% 737
2022
Q1
$17K Hold
205
﹤0.01% 695
2021
Q4
$25K Hold
205
﹤0.01% 688
2021
Q3
$25K Hold
205
﹤0.01% 675
2021
Q2
$25K Hold
205
﹤0.01% 641
2021
Q1
$22K Hold
205
﹤0.01% 706
2020
Q4
$21K Hold
205
﹤0.01% 513
2020
Q3
$17K Hold
205
﹤0.01% 527
2020
Q2
$13K Hold
205
﹤0.01% 524
2020
Q1
$13K Hold
205
﹤0.01% 496
2019
Q4
$16K Hold
205
﹤0.01% 511
2019
Q3
$16K Buy
+205
New +$16.1K ﹤0.01% 496

Other funds holding XYL

Capital Analysts LLC's XYL Position: Q2 2026 in Review

Capital Analysts LLC reduced its Xylem (XYL) stake by 33% in Q2 2026, selling an estimated $11.4K and leaving 202 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Capital Analysts LLC first reported a position in XYL in Q3 2019 and has held it in 28 quarters since. The position peaked at $45K in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Capital Analysts LLC held 202 shares of Xylem worth $24K as of Q2 2026.
  • Capital Analysts LLC sold 99 Xylem shares in Q2 2026, an estimated $11.4K.
  • Xylem made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1135 holding.
  • Capital Analysts LLC first reported a position in Xylem in Q3 2019 and has held it in 28 quarters since.
  • Capital Analysts LLC's Xylem position peaked at $45K in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.